type 2 diabetes

AFREZZA Suppresses Endogenous Glucose Production More Rapidly Than Currently Available Insulin Therapy
AFREZZA Suppresses Endogenous Glucose Production More Rapidly Than Currently Available Insulin Therapy
Yahoo/BusinessWire
Afrezza
MannKind
diabetes
type 2 diabetes
Flag link:
Amylin Soars on Roche’s Diabetes Delay
Amylin Soars on Roche’s Diabetes Delay
Barron's
Amylin
Roche
type 2 diabetes
Bydureon
Flag link:
Neurocrine agrees collaboration deal
Neurocrine agrees collaboration deal
MarketWatch
Neurocrine
Boehringer Ingelheim
type 2 diabetes
Flag link:
BYDUREON™ FDA Review Timeline Set With PDUFA Action Date Of October 22, 2010
BYDUREON™ FDA Review Timeline Set With PDUFA Action Date Of October 22, 2010
Medical News Today
Bydureon
Amylin
Eli Lilly
Alkermes
type 2 diabetes
Flag link:
GI Dynamics touts more clinical trials data
GI Dynamics touts more clinical trials data
GI Dynamics
EndoBarrier
type 2 diabetes
obesity
Flag link:
New Drug Applications Approval for Five New Products in Japan
New Drug Applications Approval for Five New Products in Japan
The Financial
Japan
Nesina
type 2 diabetes
Metact
Unisa
hypertension
Rozerem
insomnia
Vectibix
cancer
Flag link:
BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
Yahoo/PR NewsWire
Byetta
Amylin
Eli Lilly
type 2 diabetes
Flag link:
Warning: Potential Blockbuster Ahead
Warning: Potential Blockbuster Ahead
Motley Fool
Bristol-Myers Squibb
AstraZeneca
Dapagliflozin
type 2 diabetes
Flag link:

Pages